Figure 1. Schematic of our approach.

Age-sensitive transcripts are determined from a large training cohort of disease-free brains. These are used to create “molecular ages” and applied to four additional cohorts, one of which includes subjects with neurodegenerative diseases. The deviation of molecular age from chronological age (Δ age) is used to test associations of diseases and phenotypes with rates of aging of the brain.